DDDD.L Share News (DDDD)
DDDD Share
DDDD Share
DDDD Share
DDDD Share
DDDD
DDDD Share
DDDD Broker
DDDD Directors
DDDD Financial
DDDD
DDDD Short
DDDD
(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced additional positive data from its completed phase 2 trial of 'LBP Blautix' on Monday, in subjects with irritable bowel syndrome with constipation (IBS-C) or with diarrhea (IBS-D).
Read more
4d Pharma posts more "positive" results from Blautix probe
Read moreUK shareholder meetings calendar - next 7 days
Read more4D Pharma forms partnership with Parkinson's UK to improve treatments
Read moreDIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells
Read moreTRADING UPDATES: 4D Pharma loss widens on rise in administrative costs
Read more4D Pharma completes reversal into Nasdaq listing via US Spac
Read moreTRADING UPDATES: Ceres Power eyes move to Main Market by mid-2022
Read moreUK shareholder meetings calendar - next 7 days
Read moreEXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma
Read more(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced the appointment of John Beck as its chief financial officer and member of its management team on Monday.
Read more(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced the appointment of John Beck as its chief financial officer and member of its management team on Monday.
Read moreIN BRIEF: 4D Pharma appoints former Ritter finance chief as own CFO
Read more4D Pharma Registration Statements Effective; Longevity Buy Progresses
Read more(Sharecast News) - Biotherapeutics developer 4D Pharma announced a clinical trial collaboration and supply agreement with Merck and Pfizer on Monday, for 'Bavencio', or avelumab).
Read more